Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Raises $1M

NEW YORK (GenomeWeb News) – Privately-held US Genomics has raised $1 million through a sale of equity and debt securities to company executives and directors, and may raise up to $1 million more, according to a filing with the US Securities and Exchange Commission.

The Woburn, Mass.-based firm offers tools used in the extraction of high-grade DNA, tagging, microfluidics, and genomic mapping, for a range of purposes such as diagnostics, biosecurity, and food and drug monitoring.

In 2008, the firm reeled in a $4.5 million investment from Becton Dickinson as part of a collaborative agreement to develop molecular diagnostic technologies for human pathogens.

The company was not immediately available for comment to discuss its plans for the investment.